These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11739322)

  • 1. Does tamoxifen enhance endothelial function by lowering the plasma levels of homocysteine?
    Cattaneo M
    Circulation; 2001 Dec; 104(24):E146-7. PubMed ID: 11739322
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of tamoxifen on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis.
    English KM; Pugh PJ; Channer KS
    Circulation; 2001 Dec; 104(24):E146-7. PubMed ID: 11780174
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tamoxifen on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis.
    Kiortsis DN; Elisaf MS
    Circulation; 2001 Dec; 104(24):E146-7. PubMed ID: 11780173
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis.
    Clarke SC; Schofield PM; Grace AA; Metcalfe JC; Kirschenlohr HL
    Circulation; 2001 Mar; 103(11):1497-502. PubMed ID: 11257075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine--an innocent bystander in vascular disease?
    Chambers JC; Kooner JS
    Eur Heart J; 2001 May; 22(9):717-9. PubMed ID: 11350100
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes.
    Mangoni AA; Sherwood RA; Asonganyi B; Swift CG; Thomas S; Jackson SH
    Am J Hypertens; 2005 Feb; 18(2 Pt 1):220-6. PubMed ID: 15752950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine theory of atherosclerosis.
    Hladovec J
    Sb Lek; 1995; 96(3):225-30. PubMed ID: 8718812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer.
    Bogin L; Degani H
    Cancer Res; 2002 Apr; 62(7):1948-51. PubMed ID: 11929808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine. The association with atherosclerotic vascular disease in older persons.
    Aronow WS
    Geriatrics; 2003 Sep; 58(9):22-4, 27-8. PubMed ID: 14518174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine neither lowers plasma homocysteine concentrations nor improves brachial artery endothelial function in cardiac transplant recipients.
    Miner SE; Cole DE; Evrovski J; Forrest Q; Hutchison SJ; Holmes K; Ross HJ
    Can J Cardiol; 2002 May; 18(5):503-7. PubMed ID: 12032576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure.
    Scholze A; Rinder C; Beige J; Riezler R; Zidek W; Tepel M
    Circulation; 2004 Jan; 109(3):369-74. PubMed ID: 14732754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-atherosclerotic effects of tamoxifen in cholesterol-fed ovariectomized rabbits.
    Sugama D; Nakajima H; Maehara K; Hara I; Lawlor GF; Inazu M; Yamashina A; Matsumiya T
    Jpn Heart J; 2002 Sep; 43(5):545-58. PubMed ID: 12452312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction.
    Hassan A; Hunt BJ; O'Sullivan M; Bell R; D'Souza R; Jeffery S; Bamford JM; Markus HS
    Brain; 2004 Jan; 127(Pt 1):212-9. PubMed ID: 14607791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine and endothelial function in human studies.
    Moat SJ; McDowell IF
    Semin Vasc Med; 2005 May; 5(2):172-82. PubMed ID: 16047269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen and estrogen attenuate enhanced vascular reactivity induced by estrogen deficiency in rat carotid arteries.
    Tsang SY; Yao X; Chan HY; Chan FL; Leung CS; Yung LM; Au CL; Chen ZY; Laher I; Huang Y
    Biochem Pharmacol; 2007 May; 73(9):1330-9. PubMed ID: 17250811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can mild-to-moderate hyperhomocysteinaemia impair endothelial function in the absence of other risk factors for cardiovascular disease?
    Honing ML; Stehouwer CD
    Clin Sci (Lond); 2004 Apr; 106(4):345-6. PubMed ID: 14656217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate, homocysteine, endothelial function and cardiovascular disease.
    Moat SJ; Lang D; McDowell IF; Clarke ZL; Madhavan AK; Lewis MJ; Goodfellow J
    J Nutr Biochem; 2004 Feb; 15(2):64-79. PubMed ID: 14972346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.